HomeIDP • ETR
add
Biogen Inc
Previous close
€154.75
Day range
€153.50 - €153.50
Year range
€146.40 - €245.60
Market cap
23.44B USD
Avg Volume
398.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.47B | -2.55% |
Operating expense | 1.32B | -17.78% |
Net income | 388.50M | 670.48% |
Net profit margin | 15.76 | 685.87% |
Earnings per share | 4.08 | -6.42% |
EBITDA | 694.20M | 75.52% |
Effective tax rate | 13.86% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.70B | -25.73% |
Total assets | 28.31B | 0.43% |
Total liabilities | 11.95B | -12.83% |
Total equity | 16.36B | — |
Shares outstanding | 145.72M | — |
Price to book | 1.38 | — |
Return on assets | 4.64% | — |
Return on capital | 5.61% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 388.50M | 670.48% |
Cash from operations | 935.60M | 57.93% |
Cash from investing | -1.18B | 32.21% |
Cash from financing | -6.60M | -100.78% |
Net change in cash | -209.70M | 36.44% |
Free cash flow | 997.75M | 617.87% |
About
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland. Wikipedia
Founded
1978
Headquarters
Website
Employees
7,570
